TECH Long Put Strategy
TECH (Bio-Techne Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands.
TECH (Bio-Techne Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.03B, a trailing P/E of 63.87, a beta of 1.41 versus the broader market, a 52-week range of 44.12-72.16, average daily share volume of 2.5M, a public-listing history dating back to 1989, approximately 3K full-time employees. These structural characteristics shape how TECH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.41 indicates TECH has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 63.87 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. TECH pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long put on TECH?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current TECH snapshot
As of May 15, 2026, spot at $43.37, ATM IV 55.50%, IV rank 56.70%, expected move 15.91%. The long put on TECH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on TECH specifically: TECH IV at 55.50% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 15.91% (roughly $6.90 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TECH expiries trade a higher absolute premium for lower per-day decay. Position sizing on TECH should anchor to the underlying notional of $43.37 per share and to the trader's directional view on TECH stock.
TECH long put setup
The TECH long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TECH near $43.37, the first option leg uses a $43.37 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TECH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TECH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $43.37 | N/A |
TECH long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
TECH long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on TECH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on TECH
Long puts on TECH hedge an existing long TECH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying TECH exposure being hedged.
TECH thesis for this long put
The market-implied 1-standard-deviation range for TECH extends from approximately $36.47 on the downside to $50.27 on the upside. A TECH long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long TECH position with one put per 100 shares held. Current TECH IV rank near 56.70% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on TECH should anchor more to the directional view and the expected-move geometry. As a Healthcare name, TECH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TECH-specific events.
TECH long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TECH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TECH alongside the broader basket even when TECH-specific fundamentals are unchanged. Long-premium structures like a long put on TECH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current TECH chain quotes before placing a trade.
Frequently asked questions
- What is a long put on TECH?
- A long put on TECH is the long put strategy applied to TECH (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With TECH stock trading near $43.37, the strikes shown on this page are snapped to the nearest listed TECH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TECH long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the TECH long put priced from the end-of-day chain at a 30-day expiry (ATM IV 55.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TECH long put?
- The breakeven for the TECH long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TECH market-implied 1-standard-deviation expected move is approximately 15.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on TECH?
- Long puts on TECH hedge an existing long TECH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying TECH exposure being hedged.
- How does current TECH implied volatility affect this long put?
- TECH ATM IV is at 55.50% with IV rank near 56.70%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.